CD274 and non-small cell lung carcinoma: Moreover, previous data suggest that the positive correlation between the presence of irAEs and efficacy of anti-PD-(L)1 blockade agents in advanced NSCLC is not hampered by the use of corticosteroids for the treatment of irAEs, concluding that its use in this context should not be restricted for fear of loss of any outcome advantage.